Rezolute Inc (RZLT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $353.54M
Last updated: Nov 17, 2026 at 11:06 AM ET
Rezolute Inc (RZLT) Competitors
The companies most similar to Rezolute are Zevra Therapeutics (ZVRA), Rocket Pharmaceuticals (RCKT) and Regenxbio (RGNX). By market cap, Rezolute ranks 10th of the 13 companies on this page; Zevra Therapeutics (ZVRA) is the largest at $540.30M.
Peer Comparison
RZLT's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Rezolute (RZLT) | $353.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Zevra Therapeutics Inc. (ZVRA) | $540.30M | 11.6x | 3.7x | 52.8% | N/A | 44.9% | 0.00% |
| Rocket Pharmaceuticals Inc (RCKT) | $256.82M | N/A | N/A | 0.0% | -2.3% | 0.0% | 0.00% |
| Regenxbio Inc (RGNX) | $505.18M | N/A | 3.1x | -113.9% | N/A | -69.2% | 0.00% |
| PepGen Ltd (PEPG) | $410.98M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Fulcrum Therapeutics Inc (FULC) | $287.96M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Avalo Therapeutics Inc (AVTX) | $448.71M | N/A | N/A | 0.0% | N/A | -69.3% | 0.00% |
| Contineum Therapeutics, Inc. Class A Common Stock (CTNM) | $387.16M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CorMedix Inc (CRMD) | $370.64M | 6.3x | 0.9x | 15.5% | 13.9% | -47.7% | 0.00% |
| Gyre Therapeutics Inc. (GYRE) | $471.74M | N/A | 3.8x | -22.7% | N/A | 0.7% | 0.00% |
| Larimar Therapeutics Inc (LRMR) | $313.73M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Prothena Corporation plc (PRTA) | $419.01M | N/A | 7.8x | -45.4% | N/A | -74.3% | 0.00% |
| ARS Pharmaceuticals, Inc (SPRY) | $391.06M | N/A | 2.9x | -163.6% | -143.8% | 16.0% | 0.00% |
| Peer median | $401.02M | 9.0x | 3.4x | 0.0% | -2.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Rezolute, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Zevra Therapeutics Inc. (ZVRA) | Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions... | ZVRA competitors |
| Rocket Pharmaceuticals Inc (RCKT) | Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. | RCKT competitors |
| Regenxbio Inc (RGNX) | REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable... | RGNX competitors |
| PepGen Ltd (PEPG) | PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious... | PEPG competitors |
| Fulcrum Therapeutics Inc (FULC) | Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined... | FULC competitors |
| Avalo Therapeutics Inc (AVTX) | Avalo Therapeutics Inc is a forward-thinking clinical-stage biotechnology company focused on developing transformative therapies for rare and underserved... | AVTX competitors |
| Contineum Therapeutics, Inc. Class A Common Stock (CTNM) | Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies... | CTNM competitors |
| CorMedix Inc (CRMD) | CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious... | CRMD competitors |
| Gyre Therapeutics Inc. (GYRE) | Gyre Therapeutics Inc. is a pioneering biopharmaceutical company at the forefront of developing advanced therapies for rare and complex diseases. | GYRE competitors |
| Larimar Therapeutics Inc (LRMR) | Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. | LRMR competitors |
| Prothena Corporation plc (PRTA) | Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases... | PRTA competitors |
| ARS Pharmaceuticals, Inc (SPRY) | ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine aerosol with absorption technology for patients and their families at risk of severe... | SPRY competitors |
Frequently Asked Questions About RZLT
Who are Rezolute's main competitors?
The companies most similar to Rezolute include Zevra Therapeutics (ZVRA), Rocket Pharmaceuticals (RCKT), Regenxbio (RGNX), PepGen (PEPG) and Fulcrum Therapeutics (FULC), listed from the closest match.
Who is Rezolute's biggest competitor?
Zevra Therapeutics (ZVRA) is both the largest of the similar companies at $540.30M and the closest match by business profile, size, sector and industry.
How does RZLT stock compare with its competitors?
RZLT's net margin is 0.0% against a peer median of 0.0%.
Which of Rezolute's competitors pays a higher dividend?
Rezolute pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Rezolute bigger than its competitors?
No. Rezolute is 10th by market cap among the 13 companies on this page; the largest is Zevra Therapeutics (ZVRA) at $540.30M.
RZLT pages: Overview, Earnings, Forecast, Financials, Competitors